Drug Database
ES

estrogen (Estratab / esterified estrogen / Menest)

✓ Approved

AbbVie, Inc. · ESR1

什么是 estrogen?

estrogen 是一种治疗药物,由AbbVie, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Estratab, esterified estrogen, Menest
公司AbbVie, Inc.
分子靶点ESR1
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

estrogen 作用于 1 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estrogen 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresHormone replacement therapy✓ Approved

相关研究文献

PubMedFrontiers in immunology2026-09-10

The estrogen-ferroptosis axis in postmenopausal osteoporosis, osteoarthritis, and intervertebral disc degeneration: shared mechanisms and emerging evidence.

Zheng Kaiyuan K, Zhang Peiyue P, Wang Siyu S, Wang Li L et al.

Estrogen deficiency is a major risk factor for degenerative disorders of the musculoskeletal system in postmenopausal women, while ferroptosis, an iron-dependent form of programmed cell death, has been implicated in the pathogenesis of various osteoarticular diseases. Recent studies indicate an interplay between estrogen signaling and ferroptosis, with evidence relatively well supported in postmenopausal osteoporosis (PMOP), emerging in osteoarthritis (OA), and still limited in intervertebral disc degeneration (IVDD). Estrogen deficiency may disrupt iron homeostasis, lipid metabolism, and antioxidant defense systems, thereby increasing ferroptosis susceptibility across musculoskeletal tissues. This review summarizes the roles of estrogen and recent research progress in these three common degenerative diseases from the perspective of ferroptosis-related mechanisms. Particular emphasis is placed on the shared mechanisms and tissue-specific manifestations of this regulatory axis across these diseases. Finally, we highlight therapeutic opportunities and translational challenges associated with targeting this axis, including estrogen receptor subtype modulation, ferroptosis inhibition, and local delivery strategies. Overall, the estrogen-ferroptosis axis may provide a mechanistic framework for understanding postmenopausal musculoskeletal comorbidity and developing targeted interventions for degenerative musculoskeletal disorders.

PMID 42719629
阅读全文 →
PubMedJournal of industrial microbiology & biotechnology2026-09-10

A Survey of Burkholderiales Secondary Metabolites Using Library-Scale Stable Isotope Labeling Reveals Selective Production of Methyl-Esterified 3-Hydroxybutyrate Oligomers.

Zaroubi Liana L, Heard Stephanie C SC, Sutherland Matthew M, Eustaquio Alessandra S AS et al.

Large-scale untargeted bacterial metabolomics studies are often challenging to interpret, particularly for natural product discovery. Complex raw mass spectrometry data contains media components, biotransformation products, workup contaminants, and in-source fragments, making it difficult to resolve true biosynthesized bacterial products from background features. Incorporating stable isotope labels into untargeted workflows enables the selective detection of actively biosynthesized compounds, drastically reducing candidate mass spectrometry features to highlight novel or robustly expressed metabolites. Recently, our lab introduced IsoAnalyst, a parallel stable isotope labeling platform that links secondary metabolites to biosynthetic gene clusters by determining the incorporation rates of a panel of isotopically labeled building blocks. In this study we applied the IsoAnalyst protocol to a library of 114 Burkholderiales strains with the goals of profiling the specialized metabolite chemistry of this bacterial order and connecting detected natural products to their cognate BGCs based on their labeling profiles. While our strain-matching protocol, which evaluates correlations between detected metabolites and BiG-SCAPE-defined gene cluster families, did not yield confident BGC assignments, it successfully highlighted widely distributed metabolites with distinct labeling profiles. We targeted a set of these molecules for isolation, revealing two classes of compounds derived from primary biomolecule metabolism that are implicated in cellular stress responses. The first class of molecules were identified as lysophosphatidyl ethanolamine analogues while the second was characterized via NMR spectroscopy and mass spectrometry as methyl-esterified 3-hydroxybutyrate oligomers (HB6-OMe, HB7-OMe, and HB8-OMe), representing higher-degree polymer units than previously reported.

PMID 42720419
阅读全文 →
PubMedJournal of functional foods2026-09-10

Sakuranetin modulates estrogen receptor signaling in breast cancer cells.

Belgodere Jorge A JA, Nguyen Britney B, Hardgrove Anna M AM, Wheat Stephen W SW et al.

Identification of natural, bioactive compounds has been of interest to the biomedical field, in particular for the treatment of cancer. Flavonoids are a family of compounds, present across many plant species, known for their polyphenolic structure that results in cellular bioactivity. The flavonoid, sakuranetin, is produced due to external stressors, through the naringenin biosynthetic pathway. Binding affinity and docking simulations confirmed sakuranetin binding to the estrogen receptor alpha (ERα) pocket in a manner similar to, but with weaker affinity than 17β-estradiol (E2). Due to sakuranetin having chemical similarities to estrogen, this study evaluated the potential of sakuranetin to act as an endocrine modulator in estrogen receptor-positive (ERα+) breast cancer cell lines. In the ERα + cell lines, MCF-7 and T-47D, sakuranetin treatment induced dose-dependent estrogenic activity (≥ 10 μM). Sakuranetin significantly increased colony formation and cell proliferation in the MCF-7 cell line. Breast cancer cell lines with constitutively active ER through an inserted mutation in the ERα (Y537S) demonstrated no significant changes in estrogenic activity or cellular proliferation following sakuranetin treatment, except at an elevated dose (50 μM). Finaly, sakuranetin treatment enhanced genes associated with ER signaling and significantly increased ERα-mediated gene (PGR and CXCL12) expression. These results support the role of sakuranetin as a natural estrogenic compound.

PMID 42719784
阅读全文 →
PubMedmBio2026-09-10

Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-κB and TNF signaling in B cells.

Park Han-Sol H-S, Yin Anna A, Zhou Weiqiang W, Wenstedt Eliane F E EFE et al.

Sex differences in the humoral immune responses to the seasonal quadrivalent influenza vaccine (QIV) in young adults (YA; 18-49 years old) or high-dose QIV in old adults (OA; 75+ years old) were analyzed to determine how age-related changes, including in steroids, impact sex differences in B cells. Among YAs, females had greater H3N2, but not H1N1, neutralizing antibody titers, and greater proportions of hemagglutinin (HA)+ CD19+ B cells and HA+ memory B cells than males through 28 days post-vaccination (DPV), that was not observed among OAs. Machine learning algorithms illustrated that baseline (0 DPV) steroids, including 17-hydroxyprogesterone, estrogens, and testosterone, as well as HA+ CD19+ B cells and HA+ antibody-secreting B cells (ASCs), were major predictors of seroconversion at 28 DPV, particularly in YA. Single-cell RNA sequencing demonstrated that CD19+ B cells from YA females had greater transcriptional activity at 7 DPV than YA males, with upregulation of genes with estrogen-response elements (EREs) along NF-κB-mediated TNF signaling pathways in B-cell subsets, which was mitigated in OA. Estradiol treatment of ASCs from YA females, but not males, increased the number and size of HA+ IgG+ cells and expression of ERE genes along the NF-κB-mediated TNF signaling pathway,that was inhibited by an estrogen receptor antagonist. Pharmacological inhibition of either NF-κB or TNF signaling blocked the ability of E2 to upregulate antibody secretion in cells from YA females. This study provides mechanistic insights into estrogen-mediated increases in influenza vaccine-induced antibody responses among reproductive-aged females and suggests a role for estrogen signaling in the reduction of sex differences in vaccine-induced immunity with old age. Sex differences in influenza vaccine-induced immune responses become less pronounced with old age, which we hypothesize could be related to changes in circulating gonadal steroids. Our study shows that after receipt of the seasonal influenza vaccine, young adult females, who have elevated estrogenic activity, have more B cells that recognize influenza hemagglutinin; their B cells have greater activity along estrogen signaling and inflammatory pathways, and mount stronger antibody responses than young adult males, with these sex differences being mitigated in old adults. We identify estrogen as a key driver of sex differences in influenza immunity by showing that ex vivo estradiol increases antibody production by B cells through the estrogen receptor and engagement with NF-κB. These findings help explain the biological basis for sex differences in vaccine immunity and suggest that the hormonal environment, not just chronological age, shapes how well a person responds to vaccination.

PMID 42720319
阅读全文 →
PubMedJournal of the National Cancer Institute2026-09-10

Correction: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer.

PMID 42720041
阅读全文 →
PubMedFrontiers in endocrinology2026-09-10

Anti-Müllerian hormone, progesterone, and estrogen at breeding season onset and their association with reproductive performance in multiparous ewes.

Takci Abdurrahman A, Takci Tahsin T

Ovarian reserve is established during fetal life and progressively declines with age, a process accompanied by increased follicular atresia, impaired steroidogenic capacity of granulosa cells, and consequent alterations in circulating anti-Müllerian hormone (AMH), estradiol, and progesterone levels. These changes may compromise ovulatory efficiency, uterine receptivity and luteal function, thereby influencing conception rates and the risk of early pregnancy loss. Because ewes combine a long reproductive lifespan with follicular dynamics that resemble those of women, they are of interest as a large-animal model of ovarian ageing; in women, declining follicular reserve and falling AMH are established markers of reduced fertility. This study evaluated the association between serum AMH, progesterone and estrogen concentrations measured at the onset of the breeding season and subsequent reproductive performance in multiparous ewes. Forty-four multiparous kangal ewes aged 6-8 years, with a history of multiple prior parturitions, were used as study material. Blood samples were collected at the onset of the breeding season to determine serum AMH, estrogen, and progesterone concentrations. Animals were monitored throughout the breeding season for time to conception and pregnancy outcome, and were subsequently allocated into six groups: Group 1 (n=8, conceived in the 1st cycle), Group 2 (n=7, conceived in the 2nd-3rd cycle), Group 3 (n=5, conceived in the 2nd-3rd cycle but experienced pregnancy loss), Group 4 (n=8, conceived in the 4th cycle), Group 5 (n=8, conceived in the 5th-8th cycle), and Group 6 (n=8, failed to conceive throughout the breeding season). Hormone concentrations were compared among groups, and Spearman correlation analysis was performed to assess pairwise hormonal relationships. Serum AMH concentrations were significantly higher in Group 1 compared with Group 3 (P<0.01), Group 5 (P<0.01), and Group 6 (P<0.05), and in Group 2 compared with Group 3 (P<0.01) and Group 5 (P<0.01). No significant differences in AMH were observed between the remaining group pairs. Serum progesterone and estrogen concentrations did not differ significantly among groups (P>0.05). Across the entire cohort, progesterone and estrogen demonstrated a moderate positive correlation (Spearman's ρ = 0.387), indicating that animals with higher progesterone concentrations tended to have higher estrogen concentrations. This association remained significant after Benjamini-Hochberg correction within the whole-cohort correlation family (P = 0.010; q = 0.030), whereas no significant correlation was detected between AMH and progesterone (ρ = -0.248, P = 0.104) or between AMH and estrogen (ρ = -0.146, P = 0.346). None of the exploratory within-group correlations survived correction for multiple testing. Among the three hormones evaluated, AMH was the only one that differed significantly among reproductive outcome groups; progesterone and estrogen showed no significant differences, although the study was powered to detect only large effects and smaller but biologically meaningful differences cannot be excluded. These findings are consistent with the proposed value of the ewe as a model of human ovarian ageing, a parallel that currently rests on phenotypic rather than established mechanistic similarity, and indicate that AMH measured before mating is associated with subsequent reproductive performance in aged multiparous ewes. Prospective longitudinal studies using species-specific cohorts are warranted to better characterize the timeline and underlying mechanisms of ovarian aging.

PMID 42718714
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estrogen